Compare Minahasa Membangun Hebat Tbk. (HBAT) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Minahasa Membangun Hebat Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Minahasa Membangun Hebat Tbk. trades at Rp272 (market cap 283.08B), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 576.7B). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2× Minahasa Membangun Hebat Tbk.'s market cap. Which is the better fit depends on your goals.
| HBAT | LABS | |
|---|---|---|
Market Cap | 283.08B | 576.7B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Minahasa Membangun Hebat Tbk.
PT Minahasa Membangun Hebat Tbk was established based on Notarial Deed No. 44 datedJanuary 31, 2020 of Dian Fitriana, S.H., M.Kn., a public notary in Bekasi.
Read more on HBAT →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
